Target Oncology Inc

The corporation and team originated from a contract medical sales organization which launched and marketed all facets of pharmaceuticals, medical devices, diagnostics, and supportive care products. We then proceeded to concentrate our deployment in the oncology sector. We started this company, after seeing “gaps” in the quality of life for patients during cancer treatment. This lead our team to focus our attention on several of the top 6 most common side effects of cancer treatment as managing side effects is just as important as the cancer treatment in order to achieve an optimal therapeutic outcome. Our entire pipeline of products has been developed with a focus on ways to address the chief complaints cancer patients experience during treatment. We also wanted to develop products that were in line with corporate philosophies by developing products a more holistic approach to medicine. We created a pipeline of products derived from with naturally occurring compounds which demonstrate clinical evidence of activity Our family of supportive care products is designed to effectively treat the unwanted, adverse side effects of chemo and radiation treatment — helping to dramatically improve patient quality of life and outcomes during cancer treatment. These side effects can have an adverse effect on cancer treatment including a temporarily halt cancer treatment until symptoms subside.